Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
about
Choosing the right cell line for renal cell cancer researchMET Inhibition in Clear Cell Renal Cell Carcinomac-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.Targeting the VEGF pathway in metastatic bladder cancer.Systemic therapy for metastatic bladder cancer in 2016 and beyond.
P2860
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@ast
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@en
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@nl
type
label
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@ast
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@en
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@nl
prefLabel
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@ast
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@en
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@nl
P2093
P2860
P356
P1433
P1476
Characterization of HGF/Met Si ...... elial Carcinoma of the Bladder
@en
P2093
Andrea B Apolo
Piyush K Agarwal
Young H Lee
P2860
P304
P356
10.3390/CANCERS6042313
P577
2014-11-25T00:00:00Z